Shiseido Company, Limited (TYO:4911)
Japan · Delayed Price · Currency is JPY 3,159.00
+134.00 (4.43%)
Mar 27, 2026, 10:04 AM JST
Shiseido Company Revenue
In the year 2025, Shiseido Company had annual revenue of 969.99B JPY, down -2.08%. Shiseido Company had revenue of 276.18B in the quarter ending December 31, 2025, with 3.12% growth.
Revenue
969.99B
Revenue Growth
-2.08%
P/S Ratio
1.25
Revenue / Employee
36.84M
Employees
27,908
Market Cap
1.21T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 969.99B | -20.59B | -2.08% |
| Dec 31, 2024 | 990.59B | 17.55B | 1.80% |
| Dec 31, 2023 | 973.04B | -94.32B | -8.84% |
| Dec 31, 2022 | 1.07T | 32.19B | 3.11% |
| Dec 31, 2021 | 1.04T | 114.28B | 12.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kao Corporation | 1.69T |
| Paltac | 1.23T |
| Unicharm | 945.27B |
| Lion Corporation | 422.09B |
| Rohto Pharmaceutical | 335.80B |
| KOSE Holdings | 330.19B |
| Pola Orbis Holdings | 170.29B |
| Kobayashi Pharmaceutical | 165.74B |
Shiseido Company News
- 3 years ago - Boeing, Estée Lauder, and 5 Other Stocks for a Very Confusing Market - Barrons
- 5 years ago - Shiseido Refocuses On Luxury After $1.5 Billion Spin-Off To CVC Capital - Forbes
- 6 years ago - Beauty Sector Looks Promising Amid COVID-19 - Benzinga
- 6 years ago - These Large-Cap Stocks Showed Strong Performance - GuruFocus